Ved administration som en 3 timers infusion som førstevalg kemoterapi af ovariekræft, blev der rapporteret neurotoksicitet, arthralgi/ myalgi og overfølsomhed som oftere forekommende og kraftigere af patienter behandlet med paclitaxel efterfulgt af cisplatin end patienter behandlet med cyklofosfamid efterfult af cisplatin.
When administered as a 3 hour infusion for the first-line chemotherapy of ovarian cancer, neurotoxicity, arthralgia/ mayalgia, and hypersensitivity were reported as more frequent and severe by patients treated with paclitaxel followed by cisplatin than patients treated with cyclophosphamide followed by cisplatin.